首页> 外国专利> METHOD FOR SELECTING AN EFFECTIVE ANTIARRHYTHMIC AGENT FOR PATIENTS WITH PREMATURE HEART BEATS

METHOD FOR SELECTING AN EFFECTIVE ANTIARRHYTHMIC AGENT FOR PATIENTS WITH PREMATURE HEART BEATS

机译:早搏患者的有效抗心律失常药物选择方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to the field of medicine, namely to cardiology. Antiarrhythmic drugs to be tested are repeatedly applied to the patient, before each of the antiarrhythmic preparations under test, and after the beginning of their action, defined as half-life of its half-elimination. That is followed by ECG examination and determining the corrected pre-ectopic interval (PEIcor) linear deviation (LD) separately for left- and right ventricular premature heart beats (LVP and RVP), supraventricular premature heart beats (SP) in at least 20 extrasystoles. That is followed by calculating a premature heart beats index (PI), taking into account these parameters, then – ΔPI and with increase in values ΔPI≥2 units after at least two sequential preparations of the preparation, tested antiarrhythmic drug is evaluated as effective for patients with extrasystole.;EFFECT: method enables reducing the time of selecting one or more effective antiarrhythmic preparations for the patients with extrasystole.;1 cl, 11 tbl, 4 ex
机译:技术领域本发明涉及医学领域,即心脏病学。被测抗心律失常药物在每种被测抗心律失常药物制剂之前和开始作用后(被定义为其半衰期的半衰期)被反复施用于患者。然后进行ECG检查,并分别确定左室和右室早搏(LVP和RVP),室上性早搏(SP)至少20个心脏收缩期的校正后的异位间隔(PEIcor)线性偏差(LD) 。随后,考虑这些参数,计算出早搏指数(PI),然后–ΔPI并在至少两次依次制备该制剂后,随着ΔPI≥2个单位值的增加,被测抗心律不齐药物被评估为对效果:该方法可减少收缩前期患者选择一种或多种有效抗心律不齐制剂的时间。; 1 cl,11 tbl,4 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号